Lilly sets Q4 2026 dividend at $1.73

Eli Lilly and Company (LLY) has declared a fourth-quarter 2026 cash dividend of $1.73 per share on its outstanding common stock. The board’s decision sets the per-share amount for shareholders for this period and confirms the company’s latest planned distribution to equity holders.

The dividend is designated specifically for the fourth quarter of 2026, aligning with the company’s regular schedule of quarterly distributions. By setting the dividend at $1.73 per share, Eli Lilly defines the cash amount that eligible investors will receive for each share they own on the applicable record date.

The company stated that the fourth-quarter 2026 dividend will be paid on December 10, 2026. This is the date on which cash distributions are scheduled to be delivered to eligible shareholders through their brokerage or registered accounts.

To qualify for the dividend, investors must be shareholders of record at the close of business on November 13, 2026. Ownership as of this record date determines eligibility, meaning only holders recorded on the company’s books at that time will receive the $1.73 per-share payment in December.

The declaration covers Eli Lilly’s outstanding common stock, ensuring that all shares recorded as of the November 13 record date participate equally in the distribution. The record and payment dates set a clear timetable for investors tracking the company’s upcoming cash return.

By announcing a defined fourth-quarter 2026 dividend, Eli Lilly provides clarity on its planned cash return to shareholders for that period. The declared amount, record date and payment date together outline the full framework for the upcoming distribution.

The company’s communication of the $1.73 per-share figure and the specific December 10, 2026 payment date gives investors a scheduled cash flow tied to their holdings of Eli Lilly common stock. This structure allows shareholders to incorporate the dividend into their expectations for income during the fourth quarter of 2026.